Extensive White Matter Abnormalities and Clinical Symptoms in Drug-Naive Patients With First-Episode Schizophrenia

2015 ◽  
Vol 77 (02) ◽  
pp. 205-211 ◽  
Author(s):  
Xiang Yang Zhang ◽  
Feng-Mei Fan ◽  
Da-Chun Chen ◽  
Yun-Long Tan ◽  
Shu-Ping Tan ◽  
...  
2013 ◽  
Vol 43 (11) ◽  
pp. 2301-2309 ◽  
Author(s):  
Q. Wang ◽  
C. Cheung ◽  
W. Deng ◽  
M. Li ◽  
C. Huang ◽  
...  

BackgroundIt is not clear whether the progressive changes in brain microstructural deficits documented in previous longitudinal magnetic resonance imaging (MRI) studies might be due to the disease process or to other factors such as medication. It is important to explore the longitudinal alterations in white-matter (WM) microstructure in antipsychotic-naive patients with first-episode schizophrenia during the very early phase of treatment when relatively ‘free’ from chronicity.MethodThirty-five patients with first-episode schizophrenia and 22 healthy volunteers were recruited. High-resolution diffusion tensor imaging (DTI) was obtained from participants at baseline and after 6 weeks of treatment. A ‘difference map’ for each individual was calculated from the 6-week follow-up fractional anisotropy (FA) of DTI minus the baseline FA. Differences in Positive and Negative Syndrome Scale (PANSS) scores and Global Assessment of Functioning (GAF) scores between baseline and 6 weeks were also evaluated and expressed as a 6-week/baseline ratio.ResultsCompared to healthy controls, there was a significant decrease in absolute FA of WM around the bilateral anterior cingulate gyrus and the right anterior corona radiata of the frontal lobe in first-episode drug-naive patients with schizophrenia following 6 weeks of treatment. Clinical symptoms improved during this period but the change in FA did not correlate with the changes in clinical symptoms or the dose of antipsychotic medication.ConclusionsDuring the early phase of treatment, there is an acute reduction in WM FA that may be due to the effects of antipsychotic medications. However, it is not possible to entirely exclude the effects of underlying progression of illness.


2021 ◽  
Author(s):  
Qiaoling Sun ◽  
Linlin Zhao ◽  
Liwen Tan

Abstract Objective: Microstate analysis is a powerful tool to probe the brain functions, and changes in microstates under electroencephalography (EEG) have been repeatedly reported in patients with schizophrenia. This study aimed to investigate the dynamics of EEG microstates in drug-naïve, first-episode schizophrenia (FE-SCH) and to test the relationship between EEG microstates and clinical symptoms.Methods: Resting-state EEG were recorded for 23 patients with FE-SCH and 23 healthy controls using a 64-channel cap. Three parameters, i.e., contribution, duration, and occurrence, of the four microstate classes were calculated. Group differences in EEG microstates and their clinical symptoms (assessed using the Positive and Negative Syndrome Scale) were analyzed.Results: Compared with healthy controls, patients with FE-SCH showed increased duration, occurrence and contribution of microstate class C and decreased contribution and occurrence of microstate class D. In addition, the score of positive symptoms in PANSS was negatively correlated with the occurrence of microstate D.Conclusions: Our findings showed abnormal patterns of EEG microstates in drug-naïve, first-episode schizophrenia, which might help distinguish individuals with schizophrenia in the early stage and develop early intervention strategies.


2018 ◽  
Vol 45 (2) ◽  
pp. 369-376 ◽  
Author(s):  
Laila Asmal ◽  
Sanja Kilian ◽  
Stefan du Plessis ◽  
Frederika Scheffler ◽  
Bonginkosi Chiliza ◽  
...  

2019 ◽  
Vol 25 (12) ◽  
pp. 3220-3230 ◽  
Author(s):  
Xiangyang Zhang ◽  
Mi Yang ◽  
Xiangdong Du ◽  
Wei Liao ◽  
Dachun Chen ◽  
...  

2019 ◽  
Vol 25 (12) ◽  
pp. 3454-3454
Author(s):  
Xiangyang Zhang ◽  
Mi Yang ◽  
Xiangdong Du ◽  
Wei Liao ◽  
Dachun Chen ◽  
...  

2007 ◽  
Vol 164 (7) ◽  
pp. 1082-1089 ◽  
Author(s):  
Thomas J. Whitford ◽  
Stuart M. Grieve ◽  
Tom F.D. Farrow ◽  
Lavier Gomes ◽  
John Brennan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document